ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Society guideline links: COVID-19 – Hematology care (including hematologic malignancies and transplantation)

Society guideline links: COVID-19 – Hematology care (including hematologic malignancies and transplantation)

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Guidelines on oncology care, anticoagulation, and transfusion, including the use of convalescent plasma, are provided separately. (See "Society guideline links: COVID-19 – Oncology care for solid tumors" and "Society guideline links: COVID-19 – Anticoagulation" and "Society guideline links: COVID-19 – Transfusion (including convalescent plasma)".)

Links to other COVID-19-related guidelines are provided separately. (See "Society guideline links: COVID-19 – Index of guideline topics".)

Hematologic malignancies

International

Consensus Panel 5 (CP5) of the 11th International Workshop on Waldenstrom's Macroglobulinemia (IWWM-11): Report on COVID-19 prophylaxis and management (2023)

Hairy Cell Leukemia Foundation (HCLF): Hairy cell leukemia and COVID-19 adaptation of treatment guidelines (2021)

World Health Organization (WHO): Interim recommendations for an extended primary series with an additional vaccine dose for COVID-19 vaccination in immunocompromised persons (2021)

International Forum for Optimizing Care of Older Adults with Myeloma: Perspective on caring for older adults with multiple myeloma during the COVID-19 pandemic (2020)

International Lymphoma Radiation Oncology Group (ILROG): Emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic (2020)

International Society of Amyloidosis (ISA): Recommendations on the management of patients with systemic amyloidosis during the COVID-19 pandemic (2020)

United States

American Society of Clinical Oncology (ASCO): Telehealth in oncology – Standards and practice recommendations (2021)

United States Cutaneous Lymphoma Consortium (USCLC): Recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic (2020)

Europe

European Hematology Association (EHA): Expert opinions for specific hematologic malignancies

European Society for Medical Oncology (ESMO): Management and treatment adapted recommendations in the COVID-19 era – Multiple myeloma

ESMO-EHA: Clinical practice guidelines for the management of malignant lymphoma – Recommendations for the second phase of the COVID-19 pandemic: Aggressive lymphoma (diffuse large B-cell lymphoma, mantle cell and T-cell lymphomas)

ESMO-EHA: Clinical practice guidelines for the management of malignant lymphoma – Recommendations for the second phase of the COVID-19 pandemic: Hodgkin lymphoma

ESMO-EHA: Clinical practice guidelines for the management of malignant lymphoma – Recommendations for the second phase of the COVID-19 pandemic: Indolent B-NHL (follicular and marginal zone lymphoma, Waldenström's macroglobulinaemia)

European Myeloma Network (EMN): A consensus paper for management of patients with multiple myeloma and COVID-19 in the post pandemic era (2023)

European Conference on Infections in Leukaemia (ECIL): Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (published 2022)

EMN: A consensus on COVID-19 vaccination in patients with multiple myeloma (2021)

European Society for Blood and Marrow Transplantation (EBMT): Practical guidelines for the management of patients with acute leukemia during the COVID-19 outbreak (2021)

EMN: Consensus paper on management of patients with multiple myeloma in the era of COVID-19 pandemic (2020)

European Organisation for Research and Treatment of Cancer (EORTC): Management of primary cutaneous lymphoma patients during COVID‐19 pandemic (2020)

United Kingdom

British Society for Haematology (BSH): COVID-19 vaccines in patients with haematological disorders (2021)

Guidance for the management of patients with lymphoma during the COVID19 health emergency – A statement from a panel of UK lymphoma experts (2020)

Australia–New Zealand

Managing haematology and oncology patients during the COVID-19 pandemic – Interim consensus guidance (2020)

Hematopoietic cell transplantation

International

World Health Organization (WHO): Interim recommendations for an extended primary series with an additional vaccine dose for COVID-19 vaccination in immunocompromised persons (2021)

Canada

Cell Therapy Transplant Canada (CTTC): Position statement on COVID-19 vaccination (2021)

CTTC: Position statement on COVID-19 (2020)

United States

Children's Cancer and Leukaemia Group (CCLG): COVID-19 guidance for children and young people with cancer undergoing treatment (2020, updated 2022)

National Institutes of Health (NIH): COVID-19 treatment guidelines – Special considerations in solid organ transplant, hematopoietic stem cell transplant, and cellular therapy candidates, donors, and recipients (2021, updated 2022)

American Society for Transplantation and Cellular Therapy (ASTCT): Guidelines for COVID-19 management in hematopoietic cell transplantation and cellular therapy recipients (2020)

Europe

European Conference on Infections in Leukaemia (ECIL): Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (published 2022)

European Society for Blood and Marrow Transplantation (EBMT): COVID-19 vaccines (2021)

EBMT: Guidelines and recommendations for hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19 (2021)

EBMT: Recommendations on coronavirus disease COVID-19 (2020, updated 2021)

EBMT: Recommendations in relation to COVID-19 pandemic (2020)

EBMT: Recommendations on COVID-19 – Bone marrow failure and PNH (2020)

EBMT: The challenge of COVID-19 and hematopoietic cell transplantation; recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy (2020)

United Kingdom

Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC): Donor selection guidelines – Coronavirus infection (COVID-19)

National Institute for Health and Care Excellence (NICE): COVID-19 rapid guideline – Haematopoietic stem cell transplantation (2020, updated 2023)

British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT): Recommendations for the management of adult patients and allogeneic donors during the COVID-19 (causative agent the SARS-CoV-2 virus) outbreak (2020)

JPAC: Position statement on SARS-CoV-2/COVID-19 and the safety of blood, tissues and stem cells (2020)

Anemias and other cytopenias

International

In‐hospital management of persons with haemophilia and COVID‐19 – Practical guidance (2020)

Thalassaemia International Federation (TIF): Position statement on COVID-19 vaccines & haemoglobin disorders (2020)

TIF: The COVID-19 pandemic and haemoglobin disorders (2020)

TIF: The COVID-19 pandemic and haemoglobin disorders – A proposed haemoglobinopathy patient pathway: Recommendations for day care centres, units and clinics treating patients with thalassaemia and sickle cell disease (2020)

TIF: The COVID-19 pandemic and haemoglobin disorders – An informational guide on blood & COVID-19 (2020)

TIF: The COVID-19 pandemic and haemoglobin disorders – Thalassaemia & sickle cell disease: Classification of risk groups & other considerations – Guidance for patients, parents & healthcare professionals (2020)

United States

Sickle Cell Disease Association of America (SCDAA): Sickle cell disease and COVID-19 – An outline to decrease burden and minimize morbidity (2020)

Europe

European Hematology Association (EHA): Recommendations for patients with chronic neutropenia and constitutional marrow failure disorders (2020)

United Kingdom

British Society for Haematology (BSH): COVID-19 vaccines in patients with haematological disorders (2021)

BSH: Guidance on shielding for children and adults with splenectomy or splenic dysfunction during the COVID-19 pandemic (2020)

BSH: Guidance on Vitamin B12 replacement during the COVID-19 pandemic (2020)

Haemoglobinopathy Coordinating Centres (HCC): Advice on COVID-19 for patients with Diamond Blackfan anaemia (2020)

HCC: Advice on COVID-19 in patients with sickle cell disease and thalassaemia (2020)

HCC: Advice to clinicians on planning for recovery from COVID-19 (2020)

HCC: Guidance regarding iron chelation therapy in patients haemoglobin disorders or rare anaemias and cardiac iron overload if unwell with presumed or confirmed COVID-19 infection (2020)

HCC: Supporting the transfusion needs of patients with inherited red cell disorders during the COVID-19 pandemic in England – A phased approach (2020)

Hemophilia and other bleeding disorders

International

World Federation of Hemophilia (WFH): Management of COVID‐19‐associated coagulopathy in persons with haemophilia (2021)

WFH: Specific risks of COVID-19 to the bleeding disorders community (2020)

Europe

Review article – In-hospital management of persons with haemophilia and COVID-19: Practical guidance (2020)

Topic 131050 Version 20.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟